Search

Author/Creator Wiviott, Stephen D

1. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Issue 12 (December 2017)

Authors:
Sabatine, Marc S; Leiter, Lawrence A; Wiviott, Stephen D; Giugliano, Robert P; Deedwania, Prakash; De Ferrari, Gaetano M; Murphy, Sabina A; Kuder, Julia F; Gouni-Berthold, Ioanna; Lewis, Basil S; Handelsman, Yehuda; Pineda, Armando Lira; Honarpour, Narimon; Keech, Anthony C; Sever, Peter S; Peder...
Journal:
Lancet
Issue:
Volume 5:Issue 12(2017)
Page Start:
941
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (1st March 2019)

Authors:
Zelniker, Thomas A; Ruff, Christian T; Wiviott, Stephen D; Blanc, Jean-Jacques; Cappato, Riccardo; Nordio, Francesco; Mercuri, Michele F; Lanz, Hans; Antman, Elliott M; Braunwald, Eugene; Giugliano, Robert P
Journal:
European heart journal
Issue:
Volume 8:Issue 2(2019)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (March 2019)

Authors:
Zelniker, Thomas A; Ruff, Christian T; Wiviott, Stephen D; Blanc, Jean-Jacques; Cappato, Riccardo; Nordio, Francesco; Mercuri, Michele F; Lanz, Hans; Antman, Elliott M; Braunwald, Eugene; Giugliano, Robert P
Journal:
European heart journal
Issue:
Volume 8:Issue 2(2019)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. Issue 10161 (24th November 2018)

Authors:
Bohula, Erin A; Scirica, Benjamin M; Inzucchi, Silvio E; McGuire, Darren K; Keech, Anthony C; Smith, Steven R; Kanevsky, Estella; Murphy, Sabina A; Leiter, Lawrence A; Dwyer, Jamie P; Corbalan, Ramon; Hamm, Christian; Kaplan, Lee; Nicolau, Jose Carlos; Ophuis, Ton Oude; Ray, Kausik K; Ruda, Mikha...
Journal:
Lancet
Issue:
Volume 392:Issue 10161(2018)
Page Start:
2269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial. Issue 8 (August 2019)

Authors:
Mosenzon, Ofri; Wiviott, Stephen D; Cahn, Avivit; Rozenberg, Aliza; Yanuv, Ilan; Goodrich, Erica L; Murphy, Sabina A; Heerspink, Hiddo J L; Zelniker, Thomas A; Dwyer, Jamie P; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Kato, Eri T; Gause-Nilsson, Ingrid A M; Fredri...
Journal:
Lancet
Issue:
Volume 7:Issue 8(2019)
Page Start:
606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial. Issue 4 (April 2023)

Authors:
Schechter, Meir; Wiviott, Stephen D; Raz, Itamar; Goodrich, Erica L; Rozenberg, Aliza; Yanuv, Ilan; Murphy, Sabina A; Zelniker, Thomas A; Fredriksson, Martin; Johansson, Peter A; Leiter, Lawrence A; Bhatt, Deepak L; McGuire, Darren K; Wilding, John P H; Gause-Nilsson, Ingrid A M; Cahn, Avivit; La...
Journal:
Lancet
Issue:
Volume 11:Issue 4(2023)
Page Start:
233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. (28th October 2022)

Authors:
Kato, Eri Toda; Morrow, David A; Guo, Jianping; Berg, David D; Blazing, Michael A; Bohula, Erin A; Bonaca, Marc P; Cannon, Christopher P; de Lemos, James A; Giugliano, Robert P; Jarolim, Petr; Kempf, Tibor; Kristin Newby, L; O'Donoghue, Michelle L; Pfeffer, Marc A; Rifai, Nader; Wiviott, Stephen ...
Journal:
European heart journal
Issue:
Volume 44:Number 4(2023)
Page Start:
293
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Issue 7 (28th December 2021)

Authors:
Bonaca, Marc P; Antman, Elliott M; Cunningham, Jonathan W; Wiviott, Stephen D; Murphy, Sabina A; Halperin, Jonathan L; Weitz, Jeffrey I; Grosso, Michael A; Lanz, Hans J; Braunwald, Eugene; Giugliano, Robert P; Ruff, Christian T
Journal:
European heart journal
Issue:
Volume 8:Issue 7(2022)
Page Start:
695
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial . (24th August 2021)

Authors:
Oyama, Kazuma; Raz, Itamar; Cahn, Avivit; Kuder, Julia; Murphy, Sabina A; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Park, Kyong Soo; Goudev, Assen; Diaz, Rafael; Špinar, Jindřich; Gause-Nilsson, Ingrid A M; Mosenzon, Ofri; Sabatine, Marc S; Wiviott, Stephen D
Journal:
European heart journal
Issue:
Volume 43:Number 31(2022)
Page Start:
2958
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗